Circulation, Vol 71, 840-848, Copyright © 1985 by American Heart Association
B Trimarco, A Cuocolo, D Van Dorne, B Ricciardelli, M Volpe, A De Simone and M Condorelli
In chloralose-anesthetized dogs with the left circumflex coronary artery
perfused at constant flow, the effects of increasing doses of indomethacin
or naproxen on the coronary and systemic hemodynamic responses to a 5
microgram intracoronary injection of nitroglycerin (NTG) were evaluated.
The integrated areas of NTG-induced coronary vasodilatation were reduced
after administration of indomethacin or naproxen. The extent of this
reduction was increased progressively by augmenting the dose of
indomethacin and naproxen up to 1.5 and 7 mg/kg, respectively. We also
assessed the extent of cyclooxygenase inhibition induced by indomethacin or
naproxen through the radioimmunoassay of thromboxane B2, which reflects
thrombin-induced activation of platelet thromboxane A2 production during
whole blood clotting. The level of inhibition progressively increased and
complete inhibition was attained with 1.5 mg/kg indomethacin and 7 mg/kg
naproxen. Further increase in dosage failed to induce further reduction of
integrated areas of coronary vasodilatation, and a correlation was found
between the extent of the reduction of the integrated areas of coronary
vasodilatation and the dose of indomethacin (r = .828, n = 35, p less than
.001) or naproxen (r = .729, n = 35, p less than .001). Finally, the
NTG-induced maximum fall in coronary perfusion pressure remained unmodified
after inhibition of prostaglandin synthesis, but there was a faster return
of the perfusion pressure to the basal value.(ABSTRACT TRUNCATED AT 250
WORDS)
ARTICLES
Late phase of nitroglycerin-induced coronary vasodilatation blunted by inhibition of prostaglandin synthesis
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |